98%
921
2 minutes
20
Multiple sclerosis (MS) is an inflammatory-demyelinating disease of the central nervous system (CNS) mediated by aberrant auto-reactive immune responses. The current immune-modulatory therapies are unable to protect and repair immune-mediated neural tissue damage. One of the therapeutic targets in MS is the sphingosine-1-phosphate (S1P) pathway which signals via sphingosine-1-phosphate receptors 1-5 (S1P). S1P receptors are expressed predominantly on immune and CNS cells. Considering the potential neuroprotective properties of S1P signaling, we utilized S1P-GFP (Green fluorescent protein) reporter mice in the cuprizone-induced demyelination model to investigate in vivo S1P - S1P signaling in the CNS. We observed S1P signaling in a subset of neural stem cells in the subventricular zone (SVZ) during demyelination. During remyelination, S1P signaling is expressed in oligodendrocyte progenitor cells in the SVZ and mature oligodendrocytes in the medial corpus callosum (MCC). In the cuprizone model, we did not observe S1P signaling in neurons and astrocytes. We also observed β-arrestin-dependent S1P signaling in lymphocytes during demyelination and CNS inflammation. Our findings reveal β-arrestin-dependent S1P signaling in oligodendrocyte lineage cells implying a role of S1P signaling in remyelination.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444542 | PMC |
http://dx.doi.org/10.1007/s10571-022-01245-0 | DOI Listing |
J Hepatol
September 2025
Department of Neonatal Surgery, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China. Electronic address:
Background And Aims: Biliary atresia (BA) is a severe neonatal cholangiopathy characterized by progressive inflammation and fibrosis. We aimed to systematically investigate BA pathology using integrated multi-omics.
Methods: Multi-omics integration of BA and control livers revealed sphingolipid dysregulation.
Oral Radiol
September 2025
Quantitative Diagnostic Imaging, Field of Oral and Maxillofacial Imaging and Histopathological Diagnostics, Course of Applied Science, The Nippon Dental University Graduate School of Life Dentistry at Niigata, 1-8 Hamaura-cho, Chuo-ku, Niigata, Niigata, 951-8580, Japan.
Objectives: The aim of this study was performed to investigate the apparent diffusion coefficient (ADC) for distinguishing between benign and malignant lesions in submandibular and sublingual spaces.
Methods: Thirteen patients with benign and malignant lesions in submandibular and sublingual spaces were evaluated by MRI. The MRI were obtained by a 1.
J Atheroscler Thromb
September 2025
Center for Preventive Medicine, The Jikei University Hospital.
High-density lipoprotein (HDL) levels have long been inversely associated with cardiovascular disease (CVD) and are traditionally evaluated by serum HDL-cholesterol (HDL-C) levels. However, recent studies have raised doubts regarding the causal role of HDL quantity (HDL-C), drawing attention to HDL functionality. Reverse cholesterol transport (RCT) is a major anti-atherosclerotic mechanism involving ATP-binding cassette A1 (ABCA1), ATP-binding cassette G1 (ABCG1), scavenger receptor class B type I (SRB1), and regulatory factors, such as liver X receptor (LXR) and peroxisome proliferator-activated receptor gamma (PPARγ).
View Article and Find Full Text PDFPain
September 2025
Department of Pharmacology and Physiology, The Institute for Translational Neuroscience, Saint Louis University School of Medicine, St. Louis, MO, United States.
Chemotherapy-induced peripheral neuropathy accompanied by neuropathic pain (CIPN) is a major neurotoxicity of cisplatin, a platinum-based drug widely used for lung, ovarian, and testicular cancer treatment. Chemotherapy-induced peripheral neuropathy accompanied by neuropathic pain causes drug discontinuation and severely affects life quality with no FDA-approved interventions. We previously reported that platinum-based drugs increase levels of sphingosine 1-phosphate (S1P) in the spinal cord and drive CIPN through activating the S1P receptor subtype 1 (S1PR1).
View Article and Find Full Text PDFPhysiol Rev
August 2025
Unit for Metabolic Medicine, Section of Vascular Biology and Inflammation, School of Cardiovascular and Metabolic Medicine & Sciences, British Heart Foundation Centre for Research Excellence, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
Nogo-B is an endoplasmic reticulum (ER) membrane-associated protein implicated in both physiological and pathological processes, particularly those that occur within blood vessels, highly vascularized tissues, and involve inflammatory and metabolic responses. Belonging to the reticulon gene family, Nogo-B is predominantly localized to the ER and is characterized by a unique structure and membrane topology. Nogo-B's broad expression profile across multiple tissues and organs enables it to regulate numerous physiological functions and evoke responses to disease across eukaryotic organisms.
View Article and Find Full Text PDF